The results of Phase 3 trials for retatrutide have recently been announced. One of these studies followed patients over the course of 80 to 104 weeks and reported huge weight loss results and improved markers of cardiovascular disease, while another looked at its ability to treat type 2 diabetes. This article will cover how retatrutide […]









